Delivery Order SPE2DB22D3016-SPE2DB24FBCH2

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,482.30, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of a medical product, specifically 4566774952 - LIDOCAINE 5% PATCH 30S, with a performance period ending on December 23, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $3,249.75, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of March 6, 2024. This is a firm fixed-price delivery order contract. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $12,938.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565110719 ! LIDOCAINE 5% PATCH 30S, a pharmaceutical product, and has an ultimate completion date of July 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating...
This federal contract award, valued at $1,613.87, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical supply item. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $1,740.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $8,531.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LIDOCAINE 5% PATCH 30S medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,609.73 firm fixed-price contract is for the supply of LIDOCAINE 5% PATCH 30S medical products, with a period of performance through February 3, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $30,389.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567926236 LIDOCAINE 5% PATCH 30S, a medical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $2,519.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4566845553 - LIDOCAINE 5% PATCH 30S, a medical product. The contract has an ultimate completion date of January 7, 2025 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. Amerisourcebergen holds a significant...
This federal contract award, valued at $2,438.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567898916 - LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of April 15, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBCH2
    Delivery Order

This federal contract award, valued at $7,231.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a firm fixed-price delivery order contract type, is for the supply of 4565266540 - LIDOCAINE 5% PATCH 30S medical products. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely part of the company's broader portfolio of federal contracts with the DLA and other agencies, demonstrating its role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 5/17/25, 9:51 AM